Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
As of today, Johnson & Johnson(JNJ) shares are valued at $240.01. The company's market cap stands at 579.78B, with a P/E ratio of 27.85 and a dividend yield of 2.2%.
On 2026-06-14, Johnson & Johnson(JNJ) stock traded between a low of $237.52 and a high of $241.00. Shares are currently priced at $240.01, which is +1.0% above the low and -0.4% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 6.46M, against a daily average of 7.37M.
During the past year, Johnson & Johnson(JNJ) stock moved between $149.04 at its lowest and $251.71 at its peak.
During the past year, Johnson & Johnson(JNJ) stock moved between $149.04 at its lowest and $251.71 at its peak.
JNJ News
A $750,000 Portfolio That Quietly Pays You More Than the Average Social Security Check By Drew Wood Published Jun 14, 6:29AM EDT Quick Read A $750,000 income...
Why a Dividend Portfolio That Pays Your Rent May Beat Homeownership by $500,000 Over 20 Years By Drew Wood Published Jun 13, 8:02AM EDT Quick Read A $686,000...
...
Analyst ratings
68%
of 25 ratingsMore JNJ News
New insider activity at Johnson & Johnson ( (JNJ) ) has taken place on June 12, 2026. Kathryn E. Wengel, Executive Vice President, Chief TO and Risk Officer at...
Key Points Cancer remains the pharmaceutical industry's biggest business, as well as one of its fastest-growing. Some technological leaps complement existing...
Johnson & Johnson (NYSE:JNJ) has expanded U.S. availability of its TECNIS PureSee intraocular lens, described as the first FDA approved extended depth of focus...
The Dividend Growth Strategy That Turns $50,000 a Year Into $125,000 Without Investing Another Dollar By Drew Wood Published Jun 12, 8:18AM EDT Quick Read A $...
The rare blood disorder occurs when the immune system mistakenly produces IgG antibodies that attack and destroy healthy red blood cells at normal body temperat...
Johnson & Johnson is expanding the U.S. roll-out of its latest advancement in presbyopia-correcting intraocular lenses. TECNIS PureSee IOL is an extended depth...
A $2 Million Dividend Portfolio Cut Its Distribution by $14,400 in One Year and the Holders Did Not Sell By Drew Wood Published Jun 11, 5:57AM EDT Quick Read...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.